nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—NEU1—epilepsy syndrome	0.565	1	CbGaD
Oseltamivir—CES1—Rufinamide—epilepsy syndrome	0.168	0.844	CbGbCtD
Oseltamivir—SLC22A8—Valproic Acid—epilepsy syndrome	0.031	0.156	CbGbCtD
Oseltamivir—NEU1—telencephalon—epilepsy syndrome	0.00111	0.151	CbGeAlD
Oseltamivir—NEU1—medulla oblongata—epilepsy syndrome	0.000872	0.119	CbGeAlD
Oseltamivir—NEU1—midbrain—epilepsy syndrome	0.000797	0.109	CbGeAlD
Oseltamivir—NEU1—spinal cord—epilepsy syndrome	0.000778	0.106	CbGeAlD
Oseltamivir—NEU1—cerebellum—epilepsy syndrome	0.000617	0.0841	CbGeAlD
Oseltamivir—NEU1—brain—epilepsy syndrome	0.000501	0.0683	CbGeAlD
Oseltamivir—ABCC4—forebrain—epilepsy syndrome	0.000327	0.0446	CbGeAlD
Oseltamivir—CES1—head—epilepsy syndrome	0.000278	0.0379	CbGeAlD
Oseltamivir—CES1—nervous system—epilepsy syndrome	0.000264	0.0359	CbGeAlD
Oseltamivir—CES1—central nervous system—epilepsy syndrome	0.000254	0.0346	CbGeAlD
Oseltamivir—CES1—brain—epilepsy syndrome	0.000201	0.0275	CbGeAlD
Oseltamivir—ABCC4—head—epilepsy syndrome	0.000187	0.0255	CbGeAlD
Oseltamivir—SLC22A8—head—epilepsy syndrome	0.000186	0.0253	CbGeAlD
Oseltamivir—ABCC4—nervous system—epilepsy syndrome	0.000177	0.0242	CbGeAlD
Oseltamivir—SLC22A8—nervous system—epilepsy syndrome	0.000176	0.024	CbGeAlD
Oseltamivir—ABCC4—central nervous system—epilepsy syndrome	0.000171	0.0233	CbGeAlD
Oseltamivir—SLC22A8—central nervous system—epilepsy syndrome	0.000169	0.0231	CbGeAlD
Oseltamivir—ABCC4—brain—epilepsy syndrome	0.000136	0.0185	CbGeAlD
Oseltamivir—SLC22A8—brain—epilepsy syndrome	0.000134	0.0183	CbGeAlD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	7.44e-05	0.000989	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	7.44e-05	0.000989	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ST3GAL3—epilepsy syndrome	7.43e-05	0.000987	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	7.34e-05	0.000975	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ADSL—epilepsy syndrome	7.28e-05	0.000967	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NEU1—epilepsy syndrome	7.28e-05	0.000967	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—UPB1—epilepsy syndrome	7.28e-05	0.000967	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ATIC—epilepsy syndrome	7.28e-05	0.000967	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	7.15e-05	0.00095	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GLUL—epilepsy syndrome	7.14e-05	0.000948	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	7.14e-05	0.000948	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	7.14e-05	0.000948	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	7.14e-05	0.000948	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	7.08e-05	0.00094	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HSD17B4—epilepsy syndrome	7.01e-05	0.000931	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CACNA1D—epilepsy syndrome	7.01e-05	0.000931	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	6.84e-05	0.000908	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	6.81e-05	0.000904	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPP1R3C—epilepsy syndrome	6.77e-05	0.000899	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GBE1—epilepsy syndrome	6.77e-05	0.000899	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—EIF2S1—epilepsy syndrome	6.72e-05	0.000893	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	6.69e-05	0.000889	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—ACTB—epilepsy syndrome	6.64e-05	0.000882	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.62e-05	0.000878	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—SLC6A4—epilepsy syndrome	6.59e-05	0.000876	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—PLAUR—epilepsy syndrome	6.56e-05	0.000871	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—TXNRD1—epilepsy syndrome	6.56e-05	0.00087	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	6.53e-05	0.000867	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AQP1—epilepsy syndrome	6.36e-05	0.000845	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ASAH1—epilepsy syndrome	6.36e-05	0.000845	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	6.34e-05	0.000842	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	6.34e-05	0.000842	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	6.34e-05	0.000842	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	6.3e-05	0.000836	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SLC8A2—epilepsy syndrome	6.25e-05	0.00083	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—STXBP1—epilepsy syndrome	6.19e-05	0.000822	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.11e-05	0.000812	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	6.1e-05	0.000809	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	6.08e-05	0.000808	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	6.05e-05	0.000804	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	6.05e-05	0.000804	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NT5E—epilepsy syndrome	6.03e-05	0.000801	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALAD—epilepsy syndrome	6.03e-05	0.000801	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—SLC2A1—epilepsy syndrome	5.96e-05	0.000792	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SLC8A3—epilepsy syndrome	5.96e-05	0.000792	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—COX3—epilepsy syndrome	5.95e-05	0.00079	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	5.78e-05	0.000767	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CHRM3—epilepsy syndrome	5.76e-05	0.000764	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—KCNJ11—epilepsy syndrome	5.76e-05	0.000764	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CACNA1A—epilepsy syndrome	5.76e-05	0.000764	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALDH7A1—epilepsy syndrome	5.76e-05	0.000764	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—BCHE—epilepsy syndrome	5.72e-05	0.000759	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—COX3—epilepsy syndrome	5.71e-05	0.000758	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	5.64e-05	0.000749	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	5.64e-05	0.000749	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	5.64e-05	0.000749	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ST3GAL3—epilepsy syndrome	5.63e-05	0.000748	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—HBEGF—epilepsy syndrome	5.61e-05	0.000744	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Zonisamide—epilepsy syndrome	5.6e-05	0.000366	CcSEcCtD
Oseltamivir—Vomiting—Midazolam—epilepsy syndrome	5.58e-05	0.000364	CcSEcCtD
Oseltamivir—Diarrhoea—Vigabatrin—epilepsy syndrome	5.57e-05	0.000364	CcSEcCtD
Oseltamivir—Asthenia—Felbamate—epilepsy syndrome	5.57e-05	0.000364	CcSEcCtD
Oseltamivir—Arthralgia—Valproic Acid—epilepsy syndrome	5.56e-05	0.000363	CcSEcCtD
Oseltamivir—Myalgia—Valproic Acid—epilepsy syndrome	5.56e-05	0.000363	CcSEcCtD
Oseltamivir—Anxiety—Valproic Acid—epilepsy syndrome	5.54e-05	0.000362	CcSEcCtD
Oseltamivir—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.53e-05	0.000361	CcSEcCtD
Oseltamivir—Rash—Midazolam—epilepsy syndrome	5.53e-05	0.000361	CcSEcCtD
Oseltamivir—Dizziness—Fosphenytoin—epilepsy syndrome	5.53e-05	0.000361	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	5.52e-05	0.000361	CcSEcCtD
Oseltamivir—Dermatitis—Midazolam—epilepsy syndrome	5.52e-05	0.000361	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ADSL—epilepsy syndrome	5.52e-05	0.000733	CbGpPWpGaD
Oseltamivir—Urticaria—Carbamazepine—epilepsy syndrome	5.52e-05	0.00036	CcSEcCtD
Oseltamivir—Vomiting—Levetiracetam—epilepsy syndrome	5.51e-05	0.00036	CcSEcCtD
Oseltamivir—Epistaxis—Topiramate—epilepsy syndrome	5.5e-05	0.000359	CcSEcCtD
Oseltamivir—Headache—Midazolam—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Oseltamivir—Abdominal pain—Carbamazepine—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Oseltamivir—Body temperature increased—Carbamazepine—epilepsy syndrome	5.49e-05	0.000359	CcSEcCtD
Oseltamivir—Diarrhoea—Diazepam—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.49e-05	0.000358	CcSEcCtD
Oseltamivir—Sinusitis—Topiramate—epilepsy syndrome	5.47e-05	0.000357	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	5.47e-05	0.000726	CbGpPWpGaD
Oseltamivir—Rash—Levetiracetam—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Oseltamivir—Anaemia—Pregabalin—epilepsy syndrome	5.46e-05	0.000357	CcSEcCtD
Oseltamivir—Dermatitis—Levetiracetam—epilepsy syndrome	5.45e-05	0.000356	CcSEcCtD
Oseltamivir—Asthenia—Zonisamide—epilepsy syndrome	5.45e-05	0.000356	CcSEcCtD
Oseltamivir—Mental disorder—Gabapentin—epilepsy syndrome	5.45e-05	0.000356	CcSEcCtD
Oseltamivir—Agitation—Pregabalin—epilepsy syndrome	5.43e-05	0.000355	CcSEcCtD
Oseltamivir—Headache—Levetiracetam—epilepsy syndrome	5.42e-05	0.000354	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	5.42e-05	0.00072	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GLUL—epilepsy syndrome	5.41e-05	0.000718	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	5.41e-05	0.000718	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	5.41e-05	0.000718	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	5.41e-05	0.000718	CbGpPWpGaD
Oseltamivir—Angioedema—Pregabalin—epilepsy syndrome	5.4e-05	0.000353	CcSEcCtD
Oseltamivir—Hypersensitivity—Clonazepam—epilepsy syndrome	5.4e-05	0.000352	CcSEcCtD
Oseltamivir—Dizziness—Vigabatrin—epilepsy syndrome	5.39e-05	0.000352	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	5.38e-05	0.000715	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	5.38e-05	0.000715	CbGpPWpGaD
Oseltamivir—Confusional state—Valproic Acid—epilepsy syndrome	5.38e-05	0.000351	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.36e-05	0.000712	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Phenytoin—epilepsy syndrome	5.36e-05	0.00035	CcSEcCtD
Oseltamivir—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.33e-05	0.000348	CcSEcCtD
Oseltamivir—Urticaria—Lamotrigine—epilepsy syndrome	5.33e-05	0.000348	CcSEcCtD
Oseltamivir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.33e-05	0.000348	CcSEcCtD
Oseltamivir—Nausea—Propofol—epilepsy syndrome	5.32e-05	0.000348	CcSEcCtD
Oseltamivir—Vomiting—Fosphenytoin—epilepsy syndrome	5.31e-05	0.000347	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CACNA1D—epilepsy syndrome	5.31e-05	0.000705	CbGpPWpGaD
Oseltamivir—Diarrhoea—Felbamate—epilepsy syndrome	5.31e-05	0.000347	CcSEcCtD
Oseltamivir—Vertigo—Pregabalin—epilepsy syndrome	5.31e-05	0.000347	CcSEcCtD
Oseltamivir—Body temperature increased—Lamotrigine—epilepsy syndrome	5.3e-05	0.000347	CcSEcCtD
Oseltamivir—Abdominal pain—Lamotrigine—epilepsy syndrome	5.3e-05	0.000347	CcSEcCtD
Oseltamivir—Dizziness—Diazepam—epilepsy syndrome	5.3e-05	0.000346	CcSEcCtD
Oseltamivir—Infection—Valproic Acid—epilepsy syndrome	5.3e-05	0.000346	CcSEcCtD
Oseltamivir—Rash—Fosphenytoin—epilepsy syndrome	5.27e-05	0.000344	CcSEcCtD
Oseltamivir—Dermatitis—Fosphenytoin—epilepsy syndrome	5.26e-05	0.000344	CcSEcCtD
Oseltamivir—Asthenia—Clonazepam—epilepsy syndrome	5.25e-05	0.000343	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.25e-05	0.000697	CbGpPWpGaD
Oseltamivir—Back pain—Gabapentin—epilepsy syndrome	5.24e-05	0.000342	CcSEcCtD
Oseltamivir—Headache—Fosphenytoin—epilepsy syndrome	5.24e-05	0.000342	CcSEcCtD
Oseltamivir—Hepatitis—Topiramate—epilepsy syndrome	5.23e-05	0.000342	CcSEcCtD
Oseltamivir—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.23e-05	0.000342	CcSEcCtD
Oseltamivir—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.22e-05	0.000341	CcSEcCtD
Oseltamivir—Asthenia—Phenytoin—epilepsy syndrome	5.22e-05	0.000341	CcSEcCtD
Oseltamivir—Nausea—Midazolam—epilepsy syndrome	5.21e-05	0.00034	CcSEcCtD
Oseltamivir—Hallucination—Topiramate—epilepsy syndrome	5.21e-05	0.00034	CcSEcCtD
Oseltamivir—Diarrhoea—Zonisamide—epilepsy syndrome	5.2e-05	0.00034	CcSEcCtD
Oseltamivir—Asthenia—Oxcarbazepine—epilepsy syndrome	5.19e-05	0.000339	CcSEcCtD
Oseltamivir—Vomiting—Vigabatrin—epilepsy syndrome	5.18e-05	0.000338	CcSEcCtD
Oseltamivir—Skin disorder—Valproic Acid—epilepsy syndrome	5.18e-05	0.000338	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	5.16e-05	0.000685	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	5.16e-05	0.000685	CbGpPWpGaD
Oseltamivir—Cough—Pregabalin—epilepsy syndrome	5.15e-05	0.000337	CcSEcCtD
Oseltamivir—Nausea—Levetiracetam—epilepsy syndrome	5.14e-05	0.000336	CcSEcCtD
Oseltamivir—Rash—Vigabatrin—epilepsy syndrome	5.14e-05	0.000336	CcSEcCtD
Oseltamivir—Dizziness—Felbamate—epilepsy syndrome	5.13e-05	0.000335	CcSEcCtD
Oseltamivir—Dermatitis—Vigabatrin—epilepsy syndrome	5.13e-05	0.000335	CcSEcCtD
Oseltamivir—Convulsion—Pregabalin—epilepsy syndrome	5.12e-05	0.000334	CcSEcCtD
Oseltamivir—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.12e-05	0.000334	CcSEcCtD
Oseltamivir—Headache—Vigabatrin—epilepsy syndrome	5.1e-05	0.000333	CcSEcCtD
Oseltamivir—Vomiting—Diazepam—epilepsy syndrome	5.1e-05	0.000333	CcSEcCtD
Oseltamivir—Rash—Diazepam—epilepsy syndrome	5.06e-05	0.00033	CcSEcCtD
Oseltamivir—Dermatitis—Diazepam—epilepsy syndrome	5.05e-05	0.00033	CcSEcCtD
Oseltamivir—Visual impairment—Topiramate—epilepsy syndrome	5.04e-05	0.00033	CcSEcCtD
Oseltamivir—Arthralgia—Pregabalin—epilepsy syndrome	5.03e-05	0.000328	CcSEcCtD
Oseltamivir—Myalgia—Pregabalin—epilepsy syndrome	5.03e-05	0.000328	CcSEcCtD
Oseltamivir—Dizziness—Zonisamide—epilepsy syndrome	5.02e-05	0.000328	CcSEcCtD
Oseltamivir—Headache—Diazepam—epilepsy syndrome	5.02e-05	0.000328	CcSEcCtD
Oseltamivir—Anxiety—Pregabalin—epilepsy syndrome	5.01e-05	0.000327	CcSEcCtD
Oseltamivir—Diarrhoea—Clonazepam—epilepsy syndrome	5.01e-05	0.000327	CcSEcCtD
Oseltamivir—Anaemia—Gabapentin—epilepsy syndrome	5.01e-05	0.000327	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.99e-05	0.000326	CcSEcCtD
Oseltamivir—Asthenia—Carbamazepine—epilepsy syndrome	4.98e-05	0.000325	CcSEcCtD
Oseltamivir—Agitation—Gabapentin—epilepsy syndrome	4.98e-05	0.000325	CcSEcCtD
Oseltamivir—Diarrhoea—Phenytoin—epilepsy syndrome	4.98e-05	0.000325	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—PLAUR—epilepsy syndrome	4.97e-05	0.00066	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TXNRD1—epilepsy syndrome	4.97e-05	0.00066	CbGpPWpGaD
Oseltamivir—Nausea—Fosphenytoin—epilepsy syndrome	4.96e-05	0.000324	CcSEcCtD
Oseltamivir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.95e-05	0.000323	CcSEcCtD
Oseltamivir—Erythema multiforme—Topiramate—epilepsy syndrome	4.95e-05	0.000323	CcSEcCtD
Oseltamivir—Angioedema—Gabapentin—epilepsy syndrome	4.95e-05	0.000323	CcSEcCtD
Oseltamivir—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.94e-05	0.000323	CcSEcCtD
Oseltamivir—Vomiting—Felbamate—epilepsy syndrome	4.94e-05	0.000322	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	4.93e-05	0.000655	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—HMOX1—epilepsy syndrome	4.91e-05	0.000651	CbGpPWpGaD
Oseltamivir—Rash—Felbamate—epilepsy syndrome	4.89e-05	0.00032	CcSEcCtD
Oseltamivir—Eye disorder—Topiramate—epilepsy syndrome	4.89e-05	0.00032	CcSEcCtD
Oseltamivir—Dermatitis—Felbamate—epilepsy syndrome	4.89e-05	0.000319	CcSEcCtD
Oseltamivir—Vertigo—Gabapentin—epilepsy syndrome	4.87e-05	0.000318	CcSEcCtD
Oseltamivir—Headache—Felbamate—epilepsy syndrome	4.86e-05	0.000318	CcSEcCtD
Oseltamivir—Confusional state—Pregabalin—epilepsy syndrome	4.86e-05	0.000318	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.86e-05	0.000317	CcSEcCtD
Oseltamivir—Cardiac disorder—Topiramate—epilepsy syndrome	4.86e-05	0.000317	CcSEcCtD
Oseltamivir—Dizziness—Clonazepam—epilepsy syndrome	4.84e-05	0.000316	CcSEcCtD
Oseltamivir—Nausea—Vigabatrin—epilepsy syndrome	4.84e-05	0.000316	CcSEcCtD
Oseltamivir—Vomiting—Zonisamide—epilepsy syndrome	4.83e-05	0.000316	CcSEcCtD
Oseltamivir—NEU2—Metabolism—AQP1—epilepsy syndrome	4.82e-05	0.00064	CbGpPWpGaD
Oseltamivir—Insomnia—Valproic Acid—epilepsy syndrome	4.82e-05	0.000315	CcSEcCtD
Oseltamivir—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.82e-05	0.000315	CcSEcCtD
Oseltamivir—Asthenia—Lamotrigine—epilepsy syndrome	4.81e-05	0.000314	CcSEcCtD
Oseltamivir—Dizziness—Phenytoin—epilepsy syndrome	4.81e-05	0.000314	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	4.81e-05	0.000638	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	4.81e-05	0.000638	CbGpPWpGaD
Oseltamivir—Rash—Zonisamide—epilepsy syndrome	4.79e-05	0.000313	CcSEcCtD
Oseltamivir—Infection—Pregabalin—epilepsy syndrome	4.79e-05	0.000313	CcSEcCtD
Oseltamivir—Dermatitis—Zonisamide—epilepsy syndrome	4.79e-05	0.000313	CcSEcCtD
Oseltamivir—Dizziness—Oxcarbazepine—epilepsy syndrome	4.78e-05	0.000313	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—ALB—epilepsy syndrome	4.77e-05	0.000633	CbGpPWpGaD
Oseltamivir—Nausea—Diazepam—epilepsy syndrome	4.76e-05	0.000311	CcSEcCtD
Oseltamivir—Headache—Zonisamide—epilepsy syndrome	4.76e-05	0.000311	CcSEcCtD
Oseltamivir—Diarrhoea—Carbamazepine—epilepsy syndrome	4.75e-05	0.00031	CcSEcCtD
Oseltamivir—Immune system disorder—Topiramate—epilepsy syndrome	4.73e-05	0.000309	CcSEcCtD
Oseltamivir—Nervous system disorder—Pregabalin—epilepsy syndrome	4.73e-05	0.000309	CcSEcCtD
Oseltamivir—Cough—Gabapentin—epilepsy syndrome	4.73e-05	0.000309	CcSEcCtD
Oseltamivir—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.72e-05	0.000308	CcSEcCtD
Oseltamivir—Mediastinal disorder—Topiramate—epilepsy syndrome	4.72e-05	0.000308	CcSEcCtD
Oseltamivir—Dyspepsia—Valproic Acid—epilepsy syndrome	4.69e-05	0.000307	CcSEcCtD
Oseltamivir—Convulsion—Gabapentin—epilepsy syndrome	4.69e-05	0.000307	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ABCG2—epilepsy syndrome	4.69e-05	0.000623	CbGpPWpGaD
Oseltamivir—Skin disorder—Pregabalin—epilepsy syndrome	4.68e-05	0.000306	CcSEcCtD
Oseltamivir—ABCC4—Ectoderm Differentiation—FYN—epilepsy syndrome	4.68e-05	0.000621	CbGpPWpGaD
Oseltamivir—Vomiting—Clonazepam—epilepsy syndrome	4.66e-05	0.000304	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.63e-05	0.000615	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—AGT—epilepsy syndrome	4.63e-05	0.000615	CbGpPWpGaD
Oseltamivir—Vomiting—Phenytoin—epilepsy syndrome	4.62e-05	0.000302	CcSEcCtD
Oseltamivir—Rash—Clonazepam—epilepsy syndrome	4.62e-05	0.000302	CcSEcCtD
Oseltamivir—Dermatitis—Clonazepam—epilepsy syndrome	4.61e-05	0.000301	CcSEcCtD
Oseltamivir—Arthralgia—Gabapentin—epilepsy syndrome	4.61e-05	0.000301	CcSEcCtD
Oseltamivir—Myalgia—Gabapentin—epilepsy syndrome	4.61e-05	0.000301	CcSEcCtD
Oseltamivir—Nausea—Felbamate—epilepsy syndrome	4.61e-05	0.000301	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.6e-05	0.000301	CcSEcCtD
Oseltamivir—Vomiting—Oxcarbazepine—epilepsy syndrome	4.6e-05	0.000301	CcSEcCtD
Oseltamivir—Fatigue—Valproic Acid—epilepsy syndrome	4.6e-05	0.0003	CcSEcCtD
Oseltamivir—Anxiety—Gabapentin—epilepsy syndrome	4.6e-05	0.0003	CcSEcCtD
Oseltamivir—Dizziness—Carbamazepine—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Oseltamivir—Diarrhoea—Lamotrigine—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Oseltamivir—Headache—Clonazepam—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	4.59e-05	0.000609	CbGpPWpGaD
Oseltamivir—Rash—Phenytoin—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Oseltamivir—Mental disorder—Topiramate—epilepsy syndrome	4.59e-05	0.0003	CcSEcCtD
Oseltamivir—Dermatitis—Phenytoin—epilepsy syndrome	4.58e-05	0.000299	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.58e-05	0.000299	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP2C19—epilepsy syndrome	4.57e-05	0.000607	CbGpPWpGaD
Oseltamivir—Rash—Oxcarbazepine—epilepsy syndrome	4.56e-05	0.000298	CcSEcCtD
Oseltamivir—Pain—Valproic Acid—epilepsy syndrome	4.56e-05	0.000298	CcSEcCtD
Oseltamivir—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.56e-05	0.000298	CcSEcCtD
Oseltamivir—Headache—Phenytoin—epilepsy syndrome	4.56e-05	0.000298	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP11A1—epilepsy syndrome	4.54e-05	0.000603	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—epilepsy syndrome	4.54e-05	0.000603	CbGpPWpGaD
Oseltamivir—Headache—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000296	CcSEcCtD
Oseltamivir—Nausea—Zonisamide—epilepsy syndrome	4.51e-05	0.000295	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.51e-05	0.000599	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	4.51e-05	0.000598	CbGpPWpGaD
Oseltamivir—Confusional state—Gabapentin—epilepsy syndrome	4.46e-05	0.000291	CcSEcCtD
Oseltamivir—Dizziness—Lamotrigine—epilepsy syndrome	4.44e-05	0.00029	CcSEcCtD
Oseltamivir—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.42e-05	0.000289	CcSEcCtD
Oseltamivir—Vomiting—Carbamazepine—epilepsy syndrome	4.41e-05	0.000288	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	4.41e-05	0.000585	CbGpPWpGaD
Oseltamivir—Back pain—Topiramate—epilepsy syndrome	4.41e-05	0.000288	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	4.4e-05	0.000584	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	4.4e-05	0.000584	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	4.4e-05	0.000584	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	4.4e-05	0.000584	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.39e-05	0.000287	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.39e-05	0.000287	CcSEcCtD
Oseltamivir—Infection—Gabapentin—epilepsy syndrome	4.39e-05	0.000287	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—APOD—epilepsy syndrome	4.39e-05	0.000583	CbGpPWpGaD
Oseltamivir—Rash—Carbamazepine—epilepsy syndrome	4.38e-05	0.000286	CcSEcCtD
Oseltamivir—Dermatitis—Carbamazepine—epilepsy syndrome	4.37e-05	0.000286	CcSEcCtD
Oseltamivir—NEU2—Metabolism—KCNJ11—epilepsy syndrome	4.36e-05	0.000579	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CHRM3—epilepsy syndrome	4.36e-05	0.000579	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.36e-05	0.000285	CcSEcCtD
Oseltamivir—Insomnia—Pregabalin—epilepsy syndrome	4.36e-05	0.000285	CcSEcCtD
Oseltamivir—Nausea—Clonazepam—epilepsy syndrome	4.35e-05	0.000284	CcSEcCtD
Oseltamivir—Headache—Carbamazepine—epilepsy syndrome	4.35e-05	0.000284	CcSEcCtD
Oseltamivir—Nervous system disorder—Gabapentin—epilepsy syndrome	4.33e-05	0.000283	CcSEcCtD
Oseltamivir—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.33e-05	0.000283	CcSEcCtD
Oseltamivir—Nausea—Phenytoin—epilepsy syndrome	4.32e-05	0.000282	CcSEcCtD
Oseltamivir—Nausea—Oxcarbazepine—epilepsy syndrome	4.3e-05	0.000281	CcSEcCtD
Oseltamivir—Skin disorder—Gabapentin—epilepsy syndrome	4.29e-05	0.00028	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	4.28e-05	0.000568	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	4.28e-05	0.000568	CbGpPWpGaD
Oseltamivir—Vomiting—Lamotrigine—epilepsy syndrome	4.27e-05	0.000279	CcSEcCtD
Oseltamivir—Urticaria—Valproic Acid—epilepsy syndrome	4.24e-05	0.000277	CcSEcCtD
Oseltamivir—Rash—Lamotrigine—epilepsy syndrome	4.23e-05	0.000276	CcSEcCtD
Oseltamivir—Dermatitis—Lamotrigine—epilepsy syndrome	4.23e-05	0.000276	CcSEcCtD
Oseltamivir—Abdominal pain—Valproic Acid—epilepsy syndrome	4.22e-05	0.000275	CcSEcCtD
Oseltamivir—Body temperature increased—Valproic Acid—epilepsy syndrome	4.22e-05	0.000275	CcSEcCtD
Oseltamivir—Anaemia—Topiramate—epilepsy syndrome	4.21e-05	0.000275	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—APOD—epilepsy syndrome	4.21e-05	0.000559	CbGpPWpGaD
Oseltamivir—Headache—Lamotrigine—epilepsy syndrome	4.2e-05	0.000275	CcSEcCtD
Oseltamivir—Agitation—Topiramate—epilepsy syndrome	4.19e-05	0.000274	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.16e-05	0.000272	CcSEcCtD
Oseltamivir—Fatigue—Pregabalin—epilepsy syndrome	4.16e-05	0.000271	CcSEcCtD
Oseltamivir—Nausea—Carbamazepine—epilepsy syndrome	4.12e-05	0.000269	CcSEcCtD
Oseltamivir—Pain—Pregabalin—epilepsy syndrome	4.12e-05	0.000269	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.11e-05	0.000546	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP2D6—epilepsy syndrome	4.1e-05	0.000545	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	4.1e-05	0.000544	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	4.1e-05	0.000544	CbGpPWpGaD
Oseltamivir—Vertigo—Topiramate—epilepsy syndrome	4.09e-05	0.000267	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.09e-05	0.000543	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	4.08e-05	0.000542	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.06e-05	0.000539	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.03e-05	0.000263	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—TEK—epilepsy syndrome	4.03e-05	0.000535	CbGpPWpGaD
Oseltamivir—Insomnia—Gabapentin—epilepsy syndrome	4e-05	0.000261	CcSEcCtD
Oseltamivir—Nausea—Lamotrigine—epilepsy syndrome	3.99e-05	0.00026	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.98e-05	0.000528	CbGpPWpGaD
Oseltamivir—Cough—Topiramate—epilepsy syndrome	3.98e-05	0.00026	CcSEcCtD
Oseltamivir—Feeling abnormal—Pregabalin—epilepsy syndrome	3.97e-05	0.000259	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.95e-05	0.000524	CbGpPWpGaD
Oseltamivir—Convulsion—Topiramate—epilepsy syndrome	3.95e-05	0.000258	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.94e-05	0.000258	CcSEcCtD
Oseltamivir—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.93e-05	0.000257	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.92e-05	0.000521	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.91e-05	0.000519	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.91e-05	0.000519	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.91e-05	0.000519	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.91e-05	0.000519	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.91e-05	0.000519	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ADRA2A—epilepsy syndrome	3.9e-05	0.000518	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.9e-05	0.000518	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—POMC—epilepsy syndrome	3.9e-05	0.000518	CbGpPWpGaD
Oseltamivir—Dyspepsia—Gabapentin—epilepsy syndrome	3.89e-05	0.000254	CcSEcCtD
Oseltamivir—NEU1—Metabolism—BCHE—epilepsy syndrome	3.89e-05	0.000516	CbGpPWpGaD
Oseltamivir—Arthralgia—Topiramate—epilepsy syndrome	3.88e-05	0.000253	CcSEcCtD
Oseltamivir—Myalgia—Topiramate—epilepsy syndrome	3.88e-05	0.000253	CcSEcCtD
Oseltamivir—Anxiety—Topiramate—epilepsy syndrome	3.87e-05	0.000253	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.85e-05	0.000252	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.84e-05	0.00051	CbGpPWpGaD
Oseltamivir—Urticaria—Pregabalin—epilepsy syndrome	3.83e-05	0.00025	CcSEcCtD
Oseltamivir—Asthenia—Valproic Acid—epilepsy syndrome	3.83e-05	0.00025	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.82e-05	0.000249	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—CCL2—epilepsy syndrome	3.81e-05	0.000506	CbGpPWpGaD
Oseltamivir—Fatigue—Gabapentin—epilepsy syndrome	3.81e-05	0.000249	CcSEcCtD
Oseltamivir—Abdominal pain—Pregabalin—epilepsy syndrome	3.81e-05	0.000249	CcSEcCtD
Oseltamivir—Body temperature increased—Pregabalin—epilepsy syndrome	3.81e-05	0.000249	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—FLNA—epilepsy syndrome	3.79e-05	0.000503	CbGpPWpGaD
Oseltamivir—Pain—Gabapentin—epilepsy syndrome	3.78e-05	0.000247	CcSEcCtD
Oseltamivir—Confusional state—Topiramate—epilepsy syndrome	3.75e-05	0.000245	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.75e-05	0.000498	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.75e-05	0.000498	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.75e-05	0.000498	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.75e-05	0.000498	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.74e-05	0.000496	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SLC2A1—epilepsy syndrome	3.71e-05	0.000492	CbGpPWpGaD
Oseltamivir—Infection—Topiramate—epilepsy syndrome	3.69e-05	0.000241	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PLCB1—epilepsy syndrome	3.67e-05	0.000487	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—TH—epilepsy syndrome	3.66e-05	0.000485	CbGpPWpGaD
Oseltamivir—Diarrhoea—Valproic Acid—epilepsy syndrome	3.65e-05	0.000238	CcSEcCtD
Oseltamivir—Nervous system disorder—Topiramate—epilepsy syndrome	3.65e-05	0.000238	CcSEcCtD
Oseltamivir—Feeling abnormal—Gabapentin—epilepsy syndrome	3.64e-05	0.000238	CcSEcCtD
Oseltamivir—Thrombocytopenia—Topiramate—epilepsy syndrome	3.64e-05	0.000238	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.64e-05	0.000483	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.61e-05	0.000236	CcSEcCtD
Oseltamivir—Skin disorder—Topiramate—epilepsy syndrome	3.61e-05	0.000236	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3.6e-05	0.000479	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.6e-05	0.000478	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.6e-05	0.000478	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.59e-05	0.000477	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KCNMA1—epilepsy syndrome	3.59e-05	0.000477	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCG2—epilepsy syndrome	3.56e-05	0.000472	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Pregabalin—epilepsy syndrome	3.55e-05	0.000232	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—SLC8A1—epilepsy syndrome	3.55e-05	0.000471	CbGpPWpGaD
Oseltamivir—Dizziness—Valproic Acid—epilepsy syndrome	3.53e-05	0.00023	CcSEcCtD
Oseltamivir—Urticaria—Gabapentin—epilepsy syndrome	3.51e-05	0.000229	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—AGT—epilepsy syndrome	3.51e-05	0.000466	CbGpPWpGaD
Oseltamivir—Body temperature increased—Gabapentin—epilepsy syndrome	3.49e-05	0.000228	CcSEcCtD
Oseltamivir—Abdominal pain—Gabapentin—epilepsy syndrome	3.49e-05	0.000228	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.49e-05	0.000463	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.48e-05	0.000462	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.48e-05	0.000462	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.47e-05	0.000461	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2C19—epilepsy syndrome	3.47e-05	0.00046	CbGpPWpGaD
Oseltamivir—Asthenia—Pregabalin—epilepsy syndrome	3.46e-05	0.000226	CcSEcCtD
Oseltamivir—NEU2—Metabolism—CYP11A1—epilepsy syndrome	3.44e-05	0.000457	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.42e-05	0.000454	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.42e-05	0.000454	CbGpPWpGaD
Oseltamivir—Vomiting—Valproic Acid—epilepsy syndrome	3.39e-05	0.000221	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.39e-05	0.000221	CcSEcCtD
Oseltamivir—Insomnia—Topiramate—epilepsy syndrome	3.36e-05	0.00022	CcSEcCtD
Oseltamivir—Rash—Valproic Acid—epilepsy syndrome	3.36e-05	0.00022	CcSEcCtD
Oseltamivir—Dermatitis—Valproic Acid—epilepsy syndrome	3.36e-05	0.000219	CcSEcCtD
Oseltamivir—Headache—Valproic Acid—epilepsy syndrome	3.34e-05	0.000218	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.33e-05	0.000442	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.33e-05	0.000442	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.33e-05	0.000442	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CCL2—epilepsy syndrome	3.31e-05	0.000439	CbGpPWpGaD
Oseltamivir—Diarrhoea—Pregabalin—epilepsy syndrome	3.3e-05	0.000215	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—epilepsy syndrome	3.28e-05	0.000436	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.28e-05	0.000435	CbGpPWpGaD
Oseltamivir—Dyspepsia—Topiramate—epilepsy syndrome	3.27e-05	0.000214	CcSEcCtD
Oseltamivir—Hypersensitivity—Gabapentin—epilepsy syndrome	3.26e-05	0.000213	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.21e-05	0.00021	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	3.21e-05	0.000426	CbGpPWpGaD
Oseltamivir—Fatigue—Topiramate—epilepsy syndrome	3.21e-05	0.000209	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.2e-05	0.000425	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.2e-05	0.000424	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.19e-05	0.000423	CbGpPWpGaD
Oseltamivir—Dizziness—Pregabalin—epilepsy syndrome	3.19e-05	0.000208	CcSEcCtD
Oseltamivir—Pain—Topiramate—epilepsy syndrome	3.18e-05	0.000208	CcSEcCtD
Oseltamivir—Asthenia—Gabapentin—epilepsy syndrome	3.17e-05	0.000207	CcSEcCtD
Oseltamivir—Nausea—Valproic Acid—epilepsy syndrome	3.17e-05	0.000207	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	3.13e-05	0.000415	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.12e-05	0.000414	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2D6—epilepsy syndrome	3.11e-05	0.000413	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.1e-05	0.000411	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.09e-05	0.00041	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.09e-05	0.00041	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	3.08e-05	0.00041	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.07e-05	0.000407	CbGpPWpGaD
Oseltamivir—Vomiting—Pregabalin—epilepsy syndrome	3.06e-05	0.0002	CcSEcCtD
Oseltamivir—Feeling abnormal—Topiramate—epilepsy syndrome	3.06e-05	0.0002	CcSEcCtD
Oseltamivir—NEU1—Metabolism—HMOX1—epilepsy syndrome	3.05e-05	0.000405	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.04e-05	0.000199	CcSEcCtD
Oseltamivir—Rash—Pregabalin—epilepsy syndrome	3.04e-05	0.000199	CcSEcCtD
Oseltamivir—Dermatitis—Pregabalin—epilepsy syndrome	3.04e-05	0.000198	CcSEcCtD
Oseltamivir—Diarrhoea—Gabapentin—epilepsy syndrome	3.02e-05	0.000198	CcSEcCtD
Oseltamivir—Headache—Pregabalin—epilepsy syndrome	3.02e-05	0.000197	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CAT—epilepsy syndrome	3.01e-05	0.0004	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PPIA—epilepsy syndrome	2.98e-05	0.000395	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.96e-05	0.000394	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.96e-05	0.000394	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.96e-05	0.000394	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ADRA2A—epilepsy syndrome	2.96e-05	0.000393	CbGpPWpGaD
Oseltamivir—Urticaria—Topiramate—epilepsy syndrome	2.95e-05	0.000193	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—POMC—epilepsy syndrome	2.95e-05	0.000392	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—BCHE—epilepsy syndrome	2.95e-05	0.000391	CbGpPWpGaD
Oseltamivir—Abdominal pain—Topiramate—epilepsy syndrome	2.94e-05	0.000192	CcSEcCtD
Oseltamivir—Body temperature increased—Topiramate—epilepsy syndrome	2.94e-05	0.000192	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ABCB1—epilepsy syndrome	2.93e-05	0.000389	CbGpPWpGaD
Oseltamivir—Dizziness—Gabapentin—epilepsy syndrome	2.92e-05	0.000191	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—CCL2—epilepsy syndrome	2.89e-05	0.000384	CbGpPWpGaD
Oseltamivir—Nausea—Pregabalin—epilepsy syndrome	2.86e-05	0.000187	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.84e-05	0.000377	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.83e-05	0.000376	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC2A1—epilepsy syndrome	2.81e-05	0.000373	CbGpPWpGaD
Oseltamivir—Vomiting—Gabapentin—epilepsy syndrome	2.81e-05	0.000184	CcSEcCtD
Oseltamivir—Rash—Gabapentin—epilepsy syndrome	2.79e-05	0.000182	CcSEcCtD
Oseltamivir—Dermatitis—Gabapentin—epilepsy syndrome	2.78e-05	0.000182	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PLCB1—epilepsy syndrome	2.78e-05	0.000369	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TH—epilepsy syndrome	2.77e-05	0.000368	CbGpPWpGaD
Oseltamivir—Headache—Gabapentin—epilepsy syndrome	2.77e-05	0.000181	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.76e-05	0.000367	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.76e-05	0.000366	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Topiramate—epilepsy syndrome	2.74e-05	0.000179	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.73e-05	0.000362	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GPX1—epilepsy syndrome	2.72e-05	0.000361	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ATP2A2—epilepsy syndrome	2.72e-05	0.000361	CbGpPWpGaD
Oseltamivir—Asthenia—Topiramate—epilepsy syndrome	2.67e-05	0.000174	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.64e-05	0.000351	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITGA2—epilepsy syndrome	2.64e-05	0.00035	CbGpPWpGaD
Oseltamivir—Nausea—Gabapentin—epilepsy syndrome	2.63e-05	0.000172	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.55e-05	0.000338	CbGpPWpGaD
Oseltamivir—Diarrhoea—Topiramate—epilepsy syndrome	2.54e-05	0.000166	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.52e-05	0.000335	CbGpPWpGaD
Oseltamivir—Dizziness—Topiramate—epilepsy syndrome	2.46e-05	0.000161	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.46e-05	0.000326	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.42e-05	0.000321	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AGT—epilepsy syndrome	2.39e-05	0.000317	CbGpPWpGaD
Oseltamivir—Vomiting—Topiramate—epilepsy syndrome	2.36e-05	0.000154	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.35e-05	0.000313	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.35e-05	0.000312	CbGpPWpGaD
Oseltamivir—Rash—Topiramate—epilepsy syndrome	2.34e-05	0.000153	CcSEcCtD
Oseltamivir—Dermatitis—Topiramate—epilepsy syndrome	2.34e-05	0.000153	CcSEcCtD
Oseltamivir—NEU1—Metabolism—APOE—epilepsy syndrome	2.34e-05	0.000311	CbGpPWpGaD
Oseltamivir—Headache—Topiramate—epilepsy syndrome	2.33e-05	0.000152	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ADRA2A—epilepsy syndrome	2.32e-05	0.000308	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAT—epilepsy syndrome	2.31e-05	0.000307	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HMOX1—epilepsy syndrome	2.31e-05	0.000307	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CAT—epilepsy syndrome	2.28e-05	0.000303	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.24e-05	0.000297	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCB1—epilepsy syndrome	2.22e-05	0.000295	CbGpPWpGaD
Oseltamivir—Nausea—Topiramate—epilepsy syndrome	2.21e-05	0.000144	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.18e-05	0.000289	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS1—epilepsy syndrome	2.17e-05	0.000289	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ALB—epilepsy syndrome	2.11e-05	0.000281	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.09e-05	0.000277	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GPX1—epilepsy syndrome	2.06e-05	0.000274	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT3—epilepsy syndrome	2.04e-05	0.00027	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAUR—epilepsy syndrome	2.01e-05	0.000267	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—POMC—epilepsy syndrome	2.01e-05	0.000267	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2e-05	0.000266	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.99e-05	0.000265	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.94e-05	0.000257	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.91e-05	0.000254	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CDC42—epilepsy syndrome	1.86e-05	0.000247	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.84e-05	0.000245	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALB—epilepsy syndrome	1.83e-05	0.000243	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.83e-05	0.000242	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AGT—epilepsy syndrome	1.81e-05	0.00024	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—APOE—epilepsy syndrome	1.77e-05	0.000235	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.77e-05	0.000235	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—FYN—epilepsy syndrome	1.65e-05	0.00022	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.64e-05	0.000218	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.62e-05	0.000216	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—epilepsy syndrome	1.6e-05	0.000213	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—YWHAZ—epilepsy syndrome	1.59e-05	0.000211	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.57e-05	0.000209	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.57e-05	0.000209	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.56e-05	0.000207	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—POMC—epilepsy syndrome	1.52e-05	0.000202	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.51e-05	0.0002	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.5e-05	0.000199	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.46e-05	0.000193	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—epilepsy syndrome	1.41e-05	0.000187	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALB—epilepsy syndrome	1.39e-05	0.000184	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PRKCB—epilepsy syndrome	1.31e-05	0.000174	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NOS2—epilepsy syndrome	1.3e-05	0.000172	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—epilepsy syndrome	1.21e-05	0.000161	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.11e-05	0.000147	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ALB—epilepsy syndrome	1.09e-05	0.000145	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.84e-06	0.000131	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.43e-06	0.000125	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	9.3e-06	0.000123	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—epilepsy syndrome	8.05e-06	0.000107	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—epilepsy syndrome	7.71e-06	0.000102	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	7.51e-06	9.97e-05	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—epilepsy syndrome	6.1e-06	8.1e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—epilepsy syndrome	4.79e-06	6.36e-05	CbGpPWpGaD
